Trade Summary

3 days ago, Rhodes Jason P, serving as Dir at Dyne Therapeutics, Inc. (DYN), sold 227,337 shares at $18.38 per share, for a total transaction value of $4,178,516.00. Following this transaction, Rhodes Jason P now holds 1,158,923 shares of DYN.

This sale represents a 16.00% decrease in Rhodes Jason P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, April 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 30, 2026, 2 days after the trade was made.

Dyne Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.